Subtype
Pancreatobiliary Carcinoma
CI-CAN-00001365Explore in graph →
700 active trials8 approved drugs60 evidence items
- NCIt
- C166418
Loading cancer entity…
Subtype
CI-CAN-00001365Explore in graph →
Clinical trials
2,132 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (303)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04082455 | Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer | unknown | N/A | 49 | Shanghai Proton and Heavy Ion CenterOTHER | 1 | Dec 1, 2023 | clinicaltrials |
| NCT06151691 | Assessment of Early Pancreatic Cancer Prognosis by Minimal Residual Disease Using Multi-omics Approach | unknown | — | 51 | Fudan UniversityOTHER | 1 | Nov 30, 2023 | clinicaltrials |
| NCT05964621 |
| Venous Thromboembolism in Primary Pancreatic Tumour Resection(PaTR-VTE) |
| unknown |
| — |
| 64 |
| University of ThessalyOTHER |
| 1 |
| Nov 28, 2023 |
| clinicaltrials |
| NCT05600803 | Screening Single-operator Cholangioscopy for Neoplastic Bile Duct Lesions | unknown | — | 236 | Soonchunhyang University HospitalOTHER | 1 | Nov 27, 2023 | clinicaltrials |
| NCT06134193 | Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer | unknown | Phase 2 | 41 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 0 | Nov 18, 2023 | clinicaltrials |
| NCT06135649 | Dissecting the Pattern of Nodal Spread in Post-neoadjuvant Pancreatoduodenectomy | unknown | — | 850 | Universita di VeronaOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT05781958 | Cadonilimab Combined With Gem/Cis as First Line Therapy in Patients With Advanced ICC | unknown | Phase 2 | 64 | Shen FengOTHER | 1 | Nov 2, 2023 | clinicaltrials |
| NCT06106750 | Endoscopic Scissors Cutting Nasobiliary Duct VS Bilateral Plastic Stent | unknown | N/A | 122 | First People's Hospital of HangzhouOTHER | 1 | Oct 30, 2023 | clinicaltrials |
| NCT05498597 | AMT-151 in Patients With Selected Advanced Solid Tumours | unknown | Phase 1 | 30 | Multitude Therapeutics Inc.INDUSTRY | 2 | Oct 19, 2023 | clinicaltrials |
| NCT04115527 | Should a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma. | unknown | N/A | 100 | Ruijin HospitalOTHER | 1 | Oct 17, 2023 | clinicaltrials |
| NCT06081322 | A Study to Evaluate the Safety and Efficacy of PRRT With 177Lu-EB-FAPI in Patients With Advanced Cholopancreatic Tumors(CISPD-5) | unknown | Phase 1 | 29 | Zhejiang UniversityOTHER | 1 | Oct 13, 2023 | clinicaltrials |
| NCT06080854 | AG Combined With Immunotherapy and SBRT in Patients With Potentially Resectable Pancreatic Cancer | unknown | Phase 2 | 108 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Oct 12, 2023 | clinicaltrials |
| NCT04303403 | Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma | unknown | Phase 1 | 48 | National Cancer Centre, SingaporeOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT06048289 | Prospective Observational Study to Predict the Response of Biliary Tract Tumors to Immunotherapy | unknown | — | 150 | Zhejiang Cancer HospitalOTHER | 1 | Sep 25, 2023 | clinicaltrials |
| NCT06047990 | Endobiliary Percutaneous Cryobiopsy in Malignant Biliary Obstruction(BICRYOB) | unknown | N/A | 20 | Brno University HospitalOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT05681949 | Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards(ADBoard) | unknown | N/A | 1,200 | Charite University, Berlin, GermanyOTHER | 1 | Aug 24, 2023 | clinicaltrials |
| NCT05997147 | A Preoperative Model to Predict the Lymphovascular Invasion in Pancreatic Ductal Adenocarcinoma | unknown | — | 1,009 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT05023109 | GP Chemotherapy in Combination With Anti-PD-1 and Anti-TIGIT in Unresectable Advanced BTC | unknown | Phase 2 | 45 | Shanghai Zhongshan HospitalOTHER | 1 | Aug 15, 2023 | clinicaltrials |
| NCT05233293 | Spyglass+RFA Versus Cytobrush+RFA for Extrahepatic Cholangiocarcinoma | unknown | N/A | 200 | First People's Hospital of HangzhouOTHER | 1 | Aug 15, 2023 | clinicaltrials |
| NCT05957250 | [68Ga]Ga-FAPI-46 Positron Emission Tomography (PET) Scan to Improve the Imaging of Pancreatic and Bile Duct Cancer(PANSCAN-1) | unknown | N/A | 63 | Amsterdam UMC, location VUmcOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT05955092 | Exploring the Application of 3D Bioprinting for Personalized Treatment in Pancreatic Ductal Adenocarcinoma | unknown | — | 30 | Peking Union Medical College HospitalOTHER | 1 | Jul 21, 2023 | clinicaltrials |
| NCT05595122 | EUS-guided Choledochoduodenostomy for Primary Drainage of Malignant Distal Biliary Obstruction(SCORPION-II-p) | unknown | N/A | 25 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jul 20, 2023 | clinicaltrials |
| NCT04445532 | Hepatobiliary Tumors Tissue Samples Acquisition | unknown | — | 450 | Peking Union Medical College HospitalOTHER | 1 | Jul 7, 2023 | clinicaltrials |
| NCT05913661 | Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic Cholangiocarcinoma | unknown | Phase 2 | 30 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05754788 | Gene Expression Profile of Resected Pancreatic and Ampullary Adenocarcinoma at Favorable Prognosis | unknown | — | 40 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | May 26, 2023 | clinicaltrials |
| NCT03820310 | Clinical Trial of Autologous Tcm Immunotherapy in ICC | unknown | Phase 2 | 20 | Newish Technology (Beijing) Co., Ltd.INDUSTRY | 1 | May 24, 2023 | clinicaltrials |
| NCT05830019 | Carbon Ion Radiotherapy for Recurrent Pancreatic Cancer Post Surgery | unknown | N/A | 49 | Shanghai Proton and Heavy Ion CenterOTHER | 1 | Apr 26, 2023 | clinicaltrials |
| NCT05822453 | Gemcitabine Plus S1 and Tislelizumab in the First Line Therapy of Advanced Biliary Tract Carcinoma | unknown | Phase 2 | 20 | Peking Union Medical College HospitalOTHER | 1 | Apr 20, 2023 | clinicaltrials |
| NCT04164602 | The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly(NODES) | unknown | — | 2,522 | University of PecsOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT04454905 | Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study | unknown | Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT05400902 | HAIC Combined With Sintilimab and Bevacizumab for Unresectable Intrahepatic Cholangiocarcinoma | unknown | Phase 2 | 17 | Binkui LiOTHER | 1 | Apr 13, 2023 | clinicaltrials |
| NCT05805956 | IMM2902 in Patients With Advanced Solid Tumors Expressing HER2 | unknown | Phase 1 / Phase 2 | 105 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc.OTHER | 1 | Apr 10, 2023 | clinicaltrials |
| NCT04565275 | A Study of ICP-192 in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 45 | Beijing InnoCare Pharma Tech Co., Ltd.INDUSTRY | 2 | Mar 14, 2023 | clinicaltrials |
| NCT05511116 | Neoadjuvant Treatment of Resectable or Locally Advanced Borderline Pancreatic Adenocarcinoma: Reproducibility of Tumor Measurement in CT VS MRI(ReMeTTI) | unknown | — | 48 | Fondation Hôpital Saint-JosephOTHER | 1 | Mar 7, 2023 | clinicaltrials |
| NCT05374122 | AI Guidance for Biopsy in Suspected Cholangiocarcinoma | unknown | N/A | 48 | Instituto Ecuatoriano de Enfermedades DigestivasOTHER | 1 | Mar 6, 2023 | clinicaltrials |
| NCT05694845 | Evaluation of the Patient's Experience in Medical Studies for Cholangiocarcinoma | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 0 | Mar 6, 2023 | clinicaltrials |
| NCT05519319 | Safety and Efficacy of PDT vs RFA vs PDT+RFA for the Treatment of Extrahepatic Cholangiocarcinoma | unknown | N/A | 70 | First People's Hospital of HangzhouOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT05721963 | Study on the Accuracy of Proteomics in Evaluating Lymph Node Metastasis Status in Cholangiocarcinoma Patients | unknown | — | 30 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Feb 10, 2023 | clinicaltrials |
| NCT05718349 | FGF19 in Obstructive Cholestasis: "Unveil the Signal"(FOCUS) | unknown | — | 81 | Nicole HildebrandOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT04605237 | Pancreatic Cancer Recurrence in the Netherlands | unknown | — | 1,750 | UMC UtrechtOTHER | 1 | Feb 2, 2023 | clinicaltrials |
| NCT04984980 | Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab in Unresectable Biliary Tract Cancer | unknown | Phase 2 | 37 | Fudan UniversityOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05697237 | Carlizumab Plus Sovantinib in Second-line Treatment of Advanced or Metastatic Cholangiocarcinoma | unknown | N/A | 60 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 0 | Jan 25, 2023 | clinicaltrials |
| NCT04274972 | The Microbiome of Pancreatic Cancer: "PANDEMIC" Study(PANDEMIC) | unknown | — | 20 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 1 | Jan 17, 2023 | clinicaltrials |
| NCT05237193 | A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up | unknown | — | 400 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Jan 17, 2023 | clinicaltrials |
| NCT05043532 | Randomized Trial for Optimal Number of Passes Required for Molecular Profiling During EUS-FNB of Pancreatic Cancer | unknown | N/A | 33 | Orlando Health, Inc.OTHER | 1 | Jan 12, 2023 | clinicaltrials |
| NCT05672537 | Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk | unknown | Phase 2 | 70 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jan 5, 2023 | clinicaltrials |
| NCT05653817 | Advanced or Metastatic Cholangiocarcinoma | unknown | N/A | 60 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 0 | Dec 16, 2022 | clinicaltrials |
| NCT05557851 | Minnelide Along With Abraxane Plus Gemcitabine in Patients With Metastatic Adenocarcinoma of the Pancreas | unknown | Phase 1 | 36 | Minneamrita Therapeutics LLCINDUSTRY | 1 | Dec 9, 2022 | clinicaltrials |
| NCT05641233 | Preoperative Radiotherapy in Patients at High Risk of Postoperative Pancreatic Fistula After Pancreatoduodenectomy(FIBROPANC-1) | unknown | Phase 1 / Phase 2 | 33 | Erasmus Medical CenterOTHER | 1 | Dec 7, 2022 | clinicaltrials |
| NCT05634564 | Concurrent Chemoradiotherapy Combined With Immunotherapy in Patients With Potentially Resectable Pancreatic Cancer | unknown | Phase 2 | 62 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Dec 5, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Dec 1, 2023source: clinicaltrials